Actions

CD103: Revision history

View logs for this page (view abuse log)

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

4 July 2023

3 July 2023

12 June 2023

  • curprev 11:2211:22, 12 June 2023‎ John talk contribs‎ 4,623 bytes 0‎ No edit summary
  • curprev 11:2111:21, 12 June 2023‎ John talk contribs‎ 4,623 bytes +4,623‎ Created page with " <div style="background-color: #E0EEEE; {{round corners}} padding: 2em 2em; margin-right: 5px;"> :<span style="color:navy">'''Summary'''</span> :The principle use of CD103 is to identify hairy cell leukaemia (HCL) and distinguish it from related diorders. CD103 also has a wider range of applications in the histopathological identification of a range of myeloid and T-cell disorders. </div> <span style="color:navy">'''Normal expression and function'''</span> CD1..."
Retrieved from ‘https://haematologyetc.co.uk/index.php?title=CD103’